Pulse Biosciences, Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG00BRBHVD0
PLSE
Pulse Biosciences, Inc.
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Medical Instruments & Supplies
NAME
Pulse Biosciences, Inc.
ISIN
US74587B1017
TICKER
PLSE
MIC
XNAS
REUTERS
PLSE.OQ
BLOOMBERG
PLSE US
F&G:
35
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Fri, 25.04.2025
Pulse Biosciences
US74587B1017
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to five new employees as equity inducement awards outside of the Company's 2017 Equity In...
Pulse Biosciences
Thu, 24.04.2025
Pulse Biosciences
US74587B1017
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced it will report financial results for the first quarter 2025 after market close on Thursday, May 8, 2025. Company management will host a corresponding conference call beginni...
Pulse Biosciences
Wed, 23.04.2025
Pulse Biosciences
US74587B1017
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that its Nanosecond PFA technology will be featured in several presentations and a live case transmission featuring the nsPFA 360° catheter mapped with the CARTO™ 3 Mapping ...
Pulse Biosciences
Thu, 27.03.2025
Pulse Biosciences
US74587B1017
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31, 2024.
Recent Business Highlights
Soft Tissue Ablation
Announced positive p...
Pulse Biosciences
Wed, 26.03.2025
Pulse Biosciences
US74587B1017
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced plans to present at the upcoming 24th Annual Needham Virtual Health Care Conference.
Pulse Biosciences’ Management is scheduled to present on Thursday, April 10, 2025, at 9...
Pulse Biosciences
Fri, 07.03.2025
Pulse Biosciences
US74587B1017
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced it will report financial results for the fourth quarter and full year 2024 after market close on Thursday, March 27, 2025. Company management will host a corresponding confe...
Pulse Biosciences
Tue, 04.03.2025
Pulse Biosciences
US74587B1017
Pulse Biosciences, Inc. (Nasdaq: PLSE) , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to 14 new employees as equity inducement awards outside of the Company's 2017 Equity Inc...
Pulse Biosciences
Thu, 20.02.2025
Pulse Biosciences
US74587B1017
Pulse Biosciences, Inc. (Nasdaq: PLSE) , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced plans to present at the upcoming TD Cowen 45th Annual Health Care Conference in Boston.
Pulse Biosciences’ Management is scheduled to present on Wednesday, March 5, 2025, at 10:...
Pulse Biosciences
Tue, 04.02.2025
Pulse Biosciences
US74587B1017
Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced the appointment of Jon Skinner as Chief Financial Officer, effective February 3, 2025.
“I am excited to announce Jon as our next CFO...
Pulse Biosciences
Thu, 30.01.2025
Pulse Biosciences
US74587B1017
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that its nanosecond PFA Percutaneous Electrode System will be featured in a clinical science session and a video session at the North American Society for Interventional Thy...
Pulse Biosciences
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
